ctrl K

Sana Biotechnology Inc. (SANA)

NASDAQ: SANA · Real-Time Price · USD

1.92

0.02 (1.05%)

At close: May 01, 2025, 3:59 PM

1.90

-1.04%

Pre-market: May 02, 2025, 09:09 AM EDT

Sana Biotechnology Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	30.86M	27.73M	17.91M	10.17M	3.92M	1K
Gross Profit	n/a	-30.86M	-27.73M	-17.91M	-10.17M	-3.92M	-1K
Operating Income	-272.72M	-326.9M	-272.56M	-356.91M	-286.15M	-141.15M	-8.22M
Interest Income	n/a	9.94M	3.76M	676K	747K	2.86M	n/a
Pretax Income	-266.76M	-283.25M	-269.48M	-355.93M	-285.31M	-138.32M	-13.25M
Net Income	-266.76M	-283.25M	-266.39M	-344.18M	-278.64M	-130.78M	-13.25M
Selling & General & Admin	64.04M	73.3M	71.56M	50.41M	28.27M	21.78M	4.21M
Research & Development	191.94M	221.64M	201M	306.5M	257.88M	119.38M	4.01M
Other Expenses	n/a	n/a	-674K	305K	97K	-29K	n/a
Operating Expenses	281.6M	294.94M	272.56M	356.91M	286.15M	141.15M	8.22M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-4.21M
Cost & Expenses	n/a	325.81M	272.56M	356.91M	286.15M	141.15M	8.22M
Income Tax Expense	n/a	n/a	-3.09M	-11.75M	-6.67M	-7.55M	n/a
Shares Outstanding (Basic)	230.89M	194.54M	188.34M	166.43M	187.51M	187.34M	187.34M
Shares Outstanding (Diluted)	230.89M	194.54M	188.34M	166.43M	187.51M	187.34M	187.34M
EPS (Basic)	-1.16	-1.46	-1.41	-2.07	-1.49	-0.7	-0.07
EPS (Diluted)	-1.16	-1.46	-1.41	-2.07	-1.49	-0.7	-0.07
EBITDA	-251.27M	-252.39M	-256.94M	-356.91M	-287.03M	-138.9M	-13.25M
EBIT	n/a	-283.25M	-269.48M	-355.93M	-297.2M	-142.82M	-13.25M
Depreciation & Amortization	n/a	30.86M	27.73M	17.91M	10.17M	3.92M	1K